FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

2.

Report reveals lung cancer is the leading cause of cancer deaths in Florida

3.

FDA Expands Approval of Osimertinib in Lung Cancer

4.

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

5.

Venetoclax Combo Shows Promise in Younger Patients With AML


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot